MicroRNA: unveiling novel mechanistic and theranostic pathways in diabetic cardiomyopathy
Diabetic cardiomyopathy (DCM) is a prominent contributor to morbidity and mortality in people with diabetes worldwide. In diabetic patients, it is a chronic condition that is characterized by ventricular hypertrophy (VH), diastolic dysfunction, alteration of systolic function, and reduced ejection f...
Saved in:
Main Authors: | Akash De, Arnab Sarkar, Tanmoy Banerjee, Rudranil Bhowmik, Shuvam Sar, Md. Adil Shaharyar, Sanmoy Karmakar, Nilanjan Ghosh |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1613844/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanotechnology-based theranostics for bone tumors
by: Wenwen Zhan, et al.
Published: (2025-08-01) -
Exploring the complex interplay between oral Fusobacterium nucleatum infection, periodontitis, and robust microRNA induction, including multiple known oncogenic miRNAs
by: Syam Jeepipalli, et al.
Published: (2025-07-01) -
MicroRNA: a clinician’s view of the state of the problem. Part 3: MicroRNA and approaches to the treatment of cardiovascular diseases
by: O. Iu. Mironova, et al.
Published: (2023-10-01) -
Elfimova. MicroRNA: a clinician’s view of the state of the problem. Part 1. History of the issue
by: O. Iu. Mironova, et al.
Published: (2023-03-01) -
MicroRNA: a clinician's view of the state of the problem. Part 2. MicroRNA as a biomarker
by: O. Iu. Mironova, et al.
Published: (2023-05-01)